Medical network - March 16 March 15, the CFDA website the administration about 10 batches of drug unqualified notice (43, 2017). Notice, according to the drug inspection testing institute in jiangxi province and other three drug inspection institutions, labeled mastery in bad memory.didn pharmaceutical pharmaceutical group co., LTD. The three companies such as the production of 10 batches of unqualified drugs. 

 

Rejected product labeling production enterprise, drug name and batch number for: 

 

Jilin province is brilliant pharmaceutical co., LTD 

 

The production batch number is 20150403, 20160304 of ageratum vital qi pill (concentrated pill), 

 

Wuhan wujing pharmaceutical co., LTD 

 

The production batch number is 15100401, 16020401, 16040403, 16050402, the color of nucleotide sodium eye drops, 

 

Mastery in bad memory.didn pharmaceutical pharmaceutical group co., LTD 

 

Production batch number is 150901, 160201, 160301, 160201 to lamictal cefazolin sodium for injection. 

 

Unqualified project including moisture, visible foreign matter, clarity and color of solution. 

 

10 batches of substandard medicines list 

 

 

For the unqualified drugs, the relevant provinces, autonomous regions and municipalities directly under the food and drug administration has taken seized seized control measures, such as requiring companies to suspend sales use, recalls, and rectification. 

 

CFDA request production enterprises home provinces (autonomous regions and municipalities) food and drug administration of the enterprise on the basis of the pharmaceutical administration law of the People's Republic of China article seventy-four, seventy-four, seventy-five, the regulations for production and sales of unqualified drugs such as illegal behavior to carry on the investigation of public three months for production and sales of unqualified drugs companies or units processing as a result, administration of relevant situation report in time.